NCT06535503|Recruiting
Loading search results
Sponsor study identifier
observational
400
1 country
2
Study Start
July 1, 2024
Actual (reported)Primary Completion
January 1, 2025
Actual (reported)Study Completion
May 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 13, 2024
Actual (reported)July 1, 2024
Actual (reported)August 2, 2024
Actual (reported)January 1, 2025
Actual (reported)May 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Analyze STEMI patient with CS disease profile
Comorbidities, demographical information, past medical history, morbidity
5 years
Incidence of CS-complicated AMI events
The incidence of CS-complicated AMI events will show an increase over the years because of advanced diagnostic modalities and a clearer definition of CS.
5 years
Analyze treatment outcomes in the targeted population as per the patient profile
Incidence of Mortality
5 years
Analyze STEMI patient with CS disease profile
Incidence of Morbidity
5 years
Patients with STEMI complicated by cardiogenic shock on admission or after hospitalization treated at SKMC \& SSMC, Abu Dhbai
Patients with STEMI complicated by cardiogenic shock on admission or after hospitalization were treated in Abu Dhabi city from January 2020 to January 2024.
Sheikh Khalifa Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, 11001, United Arab Emirates
Al-Shamsi S, Regmi D, Govender RD. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study. BMC Cardiovasc Disord. 2019 Jun 17;19(1):148. doi: 10.1186/s12872-019-1131-2.
Akbar H, Sharma S. Acute ST-Segment Elevation Myocardial Infarction (STEMI). 2024 Oct 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK532281/
Abdulmajeed BS Alzubaidi, MD
Abu Dhabi Health Services Co. -SEHA
Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj
Sheikh Shakhbout Medical City
First Submitted
May 13, 2024
First Posted
August 2, 2024
Study Start
July 1, 2024
Actual (reported)Primary Completion
January 1, 2025
Actual (reported)The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
Analyze treatment outcomes
% of patients who were discharged
5 years
Contact the study team to confirm eligibility.
Sheikh Shakhbout Medical City (SKMC)
Abu Dhabi, Abu Dhabi Emirate, 11001, United Arab Emirates
De Luca L, Olivari Z, Farina A, Gonzini L, Lucci D, Di Chiara A, Casella G, Chiarella F, Boccanelli A, Di Pasquale G, De Servi S, Bovenzi FM, Gulizia MM, Savonitto S. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail. 2015 Nov;17(11):1124-32. doi: 10.1002/ejhf.339. Epub 2015 Sep 4.
Holmes DR Jr, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, Califf RM, Berger PB, Topol EJ. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995 Sep;26(3):668-74. doi: 10.1016/0735-1097(95)00215-p.
Shalaby G, Niazi AK, Khaled S. Cardiogenic Shock Among Patients with Acute ST-Segment Elevation Myocardial Infarction in a Middle Eastern Country: A Single-Center Experience. J Saudi Heart Assoc. 2023 Jan 20;34(4):232-240. doi: 10.37616/2212-5043.1323. eCollection 2022.
Yusufali A, Bazargani N, Muhammed K, Gabroun A, AlMazrooei A, Agrawal A, Al-Mulla A, Hajat C, Baslaib F, Philip J, Gupta P, Bakir S, Krishnan S, Almahmeed W, Alsheikh-Ali A. Opportunistic Screening for CVD Risk Factors: The Dubai Shopping for Cardiovascular Risk Study (DISCOVERY). Glob Heart. 2015 Dec;10(4):265-72. doi: 10.1016/j.gheart.2015.04.008. Epub 2015 Aug 11.
Study Completion
May 30, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 17, 2025
Record last verified: 2025-02
The plan is to share the clinical study report with all researchers. We will share the study protocol and case report form if further collaboration is decided while expanding our study.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: